chrisvoncsefalvay/vaers-outcomes huggingface dataset:
covid-19 disease after 1st vaccine; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (covid-19 disease after 1st vaccine) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced COVID-19 (covid-19 disease after 1st vaccine). At the time of the report, COVID-19 (covid-19 disease after 1st vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reporter.   Treatment information was not provided.
Early and irregular menstrual cycle.  After receiving the 2nd moderna  vaccine my menstrual cycle was almost 2 weeks early, it was also very heavy flow with  lots of blood clots, and was very painful. Every period I have had since receiving the COVID vaccine has been uncomfortable and abnormal for me. Before I had a clockwork period that would start every 28th day, flow was heaviest on day 1 and 2(never more than 3 Menstrual cups full) and then tapered off on day 3 and 4 and no cramps.  My periods( hemorrhaging, clots and cramps) are much longer than 4-5 days per-vaccine, they are now lasting  up to 2 weeks.
swollen lymph node under left arm. Spot is being iced and Advil was taken for pain and swelling. Reaction was found at 6:45 AM when child woke from sleeping
Dizzy like she's going to pass out; Achy; Tired; Feverish; Nausea; Pain in the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in the left arm), DIZZINESS (Dizzy like she's going to pass out), PAIN (Achy), FATIGUE (Tired) and PYREXIA (Feverish) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No prior medical history was reported). Concomitant products included VITAMINS NOS for an unknown indication.    On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in the left arm). On 08-Apr-2021, the patient experienced DIZZINESS (Dizzy like she's going to pass out), PAIN (Achy), FATIGUE (Tired), PYREXIA (Feverish) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain in the left arm), DIZZINESS (Dizzy like she's going to pass out), PAIN (Achy), FATIGUE (Tired), PYREXIA (Feverish) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication reported included vitamins.  Treatment details included the use of acetaminophen.
Headache, fever, uncontrolled shivering, muscle aches on night of injection. Lasted 12 hours. Was brutal and exhausting. Two weeks later developed shingles like rash on back and legs.
Patient Fainted while still seated.  Became alert after 30 seconds and felt hot/was sweating.  We gave her some cold water and she felt much better after the monitoring period and felt ok to leave the store.
Information has been received from a registered nurse concerning a 12-month-old patient who on 19-JAN-2007 was vaccinated PO with the second dose of Rotateq. It was noted that this second dose was given 3 months after the first. No problems were reported. No further information was available. There was no product quality complaint. Additional information has been requested.
pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Jan-2021 at 10:45 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 08-Jun-2021. On 30-Jan-2021 at 10:45 AM, the patient experienced EXPOSURE DURING PREGNANCY (pregnant). On 30-Jan-2021, EXPOSURE DURING PREGNANCY (pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication details were reported. No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 01-Feb-2021: Internal review on 26-JUL-2021 resulted in update of  Prospective, Birth type and fetal outcome.
Hospitalized (9.30.21);  COVID-19 positive ();  fully vaccinated  BRIEF OVERVIEW: Admission Date: 9/30/2021 Discharge Date: Oct 7, 2021 Brief history and medical decision making: 77  y/o female hx of Fallopian tube cancer with recurrent SBO. Came in with another SBO. Was responding poorly to non-surgical management. After discussion with gyn onc, patient and husband elected to go to hospice care. Had decompressive G tube placed 10/6 and went home with hospice. Does have asymptomatic COVID 19 infection.  Discharge Disposition: home with hospice/medical facility  Active Issues Requiring Follow-up: Hospice admission in patient's home 10/7/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Dehydration  Bowel obstruction  Acute kidney injury Intractable vomiting with nausea, unspecified vomiting type COVID-19 HOSPITAL COURSE: Patient is a 77 y.o female with PMHx of fallopian tube serous adenocarcinoma stage IIIc s/p chemotherapy and multiple surgeries, recurrent bowel obstruction, diastolic heart failure EF 63%, and CKD stage 4 presents with a 5-day history of nausea, vomiting, anorexia, and constipation. In the ED she was found to be hypertensive, have Bicarb of 29, Cr of 4.14, s/p 3L fluid, Reglan, Zofran. She was admitted for fluid resuscitation for dehydration and investigation of bowel obstruction. Ctap with evidence of high grade small bowel obstruction with transition point in pelvis. This is likely due to adhesions from extensive intraabdominal surgeries, however Gyn/Onc was consulted with concern for extension of malignancy. She was initially treated with medical management with antiemetics, NGT decompression, and IV fluids. She initially had BM and flatulence on 10/2, however did not tolerate NG clamping and clear liquid diet, thus NG decompression resumed. Gyn/Onc discussed treatment options with patient, and ultimately reached the decision to pursue hospice. A G-tube was placed for decompression per IR. Hospice was coordinated for home and discharge on 10/7. Her hospital course was complicated by AKI on CKD and hypokalemia, which improved with IV fluid maintenance. Additionally, she was incidentally found to be COVID-19 positive, intermittently required 2L NC however mostly asymptomatic from a respiratory standpoint throughout her stay.
states that "they" got their first dose and then "they" got covid that week; This is a spontaneous report from a contactable consumer (wife). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown, expiry date: unknown), via unspecified route of administration, on an unspecified date, as a single dose for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. Reporter stated that "they" got their first dose and then "they" got covid that week, on an unspecified date. She called because "they" are trying to get a second dose but were a little nervous about "how it's going to hit us." Reporter stated that someone said it can wait up to six weeks and asked if that is true. She was not sure about the current recommendation, but medical information team has that Information. She stated that she thinks "they" caught covid from her husband's work ("they" presumably is referring to her and her husband) and that it has nothing to do with the vaccine. She stated her parents both had moderna and they have been around them and her parents did not catch covid. If she changed her mind after the second vaccine, she would call back to give us her information. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained.
This case was reported by a nurse and described the occurrence of incorrect storage of drug in a patient who received HAVRIX. Co-suspect products included ROTARIX, BOOSTRIX and KINRIX. On an unknown date, the patient received HAVRIX at an unknown dose, ROTARIX at an unknown dose, BOOSTRIX at an unknown dose and KINRIX at an unknown dose. On an unknown date, an unknown time after receiving HAVRIX, ROTARIX, BOOSTRIX and KINRIX, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. Additional information received: HAVRIX, ROTARIX, BOOSTRIX and KINRIX were exposed to a low temp. of 31F between 4/2/14 and 4/18/14 for a total of 336 hours. These vaccines were then administered to patients after exposed to this temp. The HCP does know the patient initials, M/F, DOB, lot #, exp. date, etc. for each dose given as he just found out that these doses should be counted as valid (per CDC).
pt states that on the afternoon of vax cried for 3-4 hrs continuously; seen by MD; no tx was given; mom was advised to cont w/APAP; temp was never above 99;
Patient started having headache and dizziness 2 hrs after vaccine,  dizziness resolved after 24 hr, then  started complain about  knee pain and weakness on lower limb 24hrs after vaccine. Patient was transfer to Hospital for Further evaluation of sudden onset of lower limb weakness. We called hopspital and Hospital accepted the transfer. Patient appears well and walked out of office with some assistance
I did not have a reaction to the vaccine. I started feeling symptoms on 09/12/2022 of a fever, chills, fatigue, muscle aches, congestion, runny nose, shortness of breath and nausea. On 09/13/22, I tested positive for COVID-19 with home test. I contacted my doctor and since I take certain medication, I was unable to get the prescription for PAXLOVID. I took over the counter medication for my symptoms. I isolated for ten days, and the symptoms subsided on day seven.
This case was reported by a consumer via out of hour services and described the occurrence of fever in a adult patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 2nd dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced fever and injection site pain. On an unknown date, the outcome of the fever and injection site pain were unknown. It was unknown if the reporter considered the fever and injection site pain to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient's body temperature was recorded as 100.6 degree F. Lab Comments: Lab test performed on an unknown date.
Pain in left arm where shot was administered. Began the morning after received the vaccine.  Migraine-like headache and flu-like discomfort (coughing, chills) began later that evening. Did not sleep at all on the 2nd night. Chills and headache are still present.
Ran a fever of 106 degrees, went into a seizure. Had to call EMS. Admitted to the hospital. Broke out in a strange looking rash. The hospital discharge summary states viral syndrome.
Received two doses of COVID19 Janssen. Recommendation is one dose.  1st shot 03SEP21 COVID19 (Janssen)/ Janssen/ LOT 1816027/ intramuscular/ arm unk 2nd shot 17SEP21 COVID19 (Janssen)/ Janssen/ LOT 043a21a/ intramuscular/ arm unk  All vaccines in block 17 administered on 09/17/2021
Still positive for Covid antibodies after infection a year ago; Severe body aches; chills; sweats; cough; headache; elbow pain on site arm; This is a spontaneous report from a contactable consumer (her sellf). A 33-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTEC COVID-19 VACCINE, Solution for injection, Batch/Lot number and expiry date was not reported), via an unspecified route of administration, in right arm on 02Mar2021 09:30 (at the age of 33-years-old) as a single dose for covid-19 immunisation. Medical history included tachycardia and COVID-19. The patient did not have any allergies to medications, food or other products. The patient's concomitant medications were not reported. The patient received other medications in 2 weeks of vaccination. Patient did not receive other vaccine in four weeks of vaccination. Patient had COVID prior vaccination. Post vaccination the patient tested for COVID on 03Mar2021, test type: Nasal Swab, test name: ID NOW RNA PCR and result was negative. The outcome of still positive for COVID antibodies after infection a year ago was not recovered and for the other events was unknown.
This spontaneous report was received from a pharmacist refers to a 60 years old female patient. On 12-SEP-2012, the patient was vaccinated subcutaneously with dose 1, 0.65 ml ZOSTAVAX lot # (972930/0598AE). No concomitant medications were reported. On 12-SEP-2012, the patient experienced significant bleeding and bruising at the injection site. The bleeding lasted a few seconds and the bruising was "quarter sized". No treatment information was reported. The outcome of significant bleeding and bruising at the injection site was unknown. The relatedness for significant bleeding and bruising at the injection site was unknown for ZOSTAVAX. Additional information has been requested.
Extreme lower Extremity pain; like running a marathon; Red swollen lumps in legs; fever; chills and sweats This has been currently going on for 12 days with fever everyday up to 103
joint pain &    cold symptoms, diarrhea & nauseam ,   high pressure , lethatgy,  called dr. and was treaTED OVER PHONE
Itching; She has been breaking out on her arm, neck, and back; She found bumps on the side of her face; This is a spontaneous report from a contactable consumer. This female consumer (patient) reported that a 55-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 Vaccine, solution for injection, Lot Number: EW0161) via an unspecified route of administration, administered in Arm Left on 05May2021 (55-year-old at the time of vaccination) as dose 2, single for covid-19 immunisation. The patient medical history was not reported. The concomitant medications were reported as yes (not specified). Historical vaccine included first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE solution for injection, Lot Number: ER8733), via an unspecified route of administration, administered in Arm Left on 14Apr2021 as dose 1, single for COVID-19 immunization. On an unspecified date of 2021, the patient experienced itching, she has been breaking out on her arm, neck, and back, ear and her arm and bumps on the side of her face. The patient took the second shot last week on 05May2021, and since she has been itching. She has been breaking out on her arm, neck, and back. It was off and on. The patient would come home from work, and undress and be itching. It was weird. The patient did not have a prescribing doctor. She had no side effects with the first shot. This itching was like 50/50, but it has not improved. It was annoying the patient. It comes and goes. Today she noticed it on her arm. Today it is on the back of her ear and her arm. When the patient gets undressed it was going down her leg. There are several places on her face that started itching today. She found bumps on the side of her face. Therapeutic measures were taken as a result of itching using calamine lotion on itchy spots, and she may go get some Benadryl. Her cousin works in the lab. The outcome of the event Itching was not recovered while other events was unknown.  No follow-up attempts are needed. No further information is expected.
She tested positive on 20Jan and is currently asymptomatic; She tested positive on 20Jan and is currently asymptomatic; This is a spontaneous report from a contactable nurse (patient) from a Pfizer-sponsored program. The 84-years-old female patient received first dose of bnt162b2 (BNT162B2, lot number: EL1283), via an unspecified route of administration on 13Jan2021 at SINGLE DOSE as Preventive and healthcare worker. Medical history and concomitant medications were none. Caller received the first dose of the vaccine on 13Jan. She tested positive on 20Jan and is currently asymptomatic. Her next dose of the vaccine is due on 29Jan and wants to know if she should get this at a later date. The outcome of the events was not recovered.  No follow-up attempts are possible, information on batch number cannot be obtained.; Sender's Comments: A causal association between BNT162B2 and the reported events cannot be excluded based on a compatible temporal relation. However, full immunity is only expected 2 weeks after the second dose.
Headaches, Fever, Nausea, malaise 3 hours after admin. Sent to ER by ambulance.
Patient developed bruising and red rash at lower half of upper left arm. No reaction near injection site, but reaction an arm of injection.
This spontaneous report was received from a consumer (the patient's mother) and refers to a female patient of unknown age. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. On an unknown date in 2008, the patient was vaccinated with GARDASIL (dose, lot #, expiry date, route of administration and anatomical location were not reported). On an unknown date, about a month after receiving GARDASIL, the patient experienced injury in her ankle. The reporter stated that, now she had medical bills related to unspecified type of medical problems that happened after receiving GARDASIL. Product quality complaint (PQC) was not involved. The outcome of the events and causality assessment were not provided. Additional information is not expected as no contact details were provided.
Pt recvd vax 19AUG93 & devel purpura, fever, & was unable to urinate; pt was admitted to hosp where sx described as Henoch-Schonlein Purpura;
pt recvd vax & had t>102; rash x 3; yeast rash groin area;
Abnormal painful cramping and large numerous blood clots during menses following vaccination.  Experienced  sore joints for several months after vaccination.
No contraindications to vaccine on screening.  Client give Tdap vaccination with father present and immediately reported dizziness.  Her color was pink, skin warm to touch, speaking and oriented at that time.  Had client rest head between her knees while remaining in seat and dizziness resolved within one minute.  She denied dizziness on standing and walked steadily to waiting area for post-vaccination monitoring.  I was then summoned to waiting area 2-3 minutes post vaccination as client had collapsed in her chair beside father.  She was limp and pale in color on approach.  She responded by opening her eyes when I lifted her to lower her to floor to supine position.  She was oriented x 3 immediately upon laying on floor.  No further episodes of unresponsiveness.  Color returned to normal within minutes.  Cool pack applied to forehead.  Father reports client spasmed briefly in chair and bumped head on wall seconds prior to collapse.  No history of seizures per father.  Vitals and neuros within normal limits post incident.
Vertigo; Ataxia; This is a spontaneous report from a contactable other healthcare professional (patient herself).  A 64-year-old female patient (not pregnant) received her first dose of bnt162b2 (BNT162B2 also reported as product COVID 19 vaccine brand Pfizer, lot EL3302), intramuscularly in the left arm on 20Jan2021 10:15 at SINGLE DOSE for Covid-19 vaccination. The patient's medical history was not reported. No known allergies. No Covid prior to vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID), naproxen sodium (NAPROSYN), sertraline hydrochloride (ZOLOFT) and esomeprazole sodium (NEXIUM). The patient experienced vertigo and ataxia on 21Jan2021 08:30. No treatment was given. The outcome of events was recovering.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE NON ST ELEVATION MI 5/26/2022  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
receiving expired dose; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (receiving expired dose) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (receiving expired dose). At the time of the report, EXPIRED PRODUCT ADMINISTERED (receiving expired dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. Patient administered second booster dose.   No treatment medication was provided.
8/12 grandmother reported small blister dime size formed on right thigh.  It may be do to DTaP or MMR vaccine
About 3 to 4 hours after receiving my 1st dose I started to feel tingling in my lips, mouth, and tongue. I also felt a tightness in my chest. I became shortened of breath to get up the stairs. I live in a 3 story house and on 3rd floor I was having a wheezing cough after going up the stairs. I started having hives on my lips. Around 4 hours later I sent a selfie to my brother who is a doctor. He advised me to take all of my allergy medicine so I did. He said if my breathing became compromised then I should go to the ER but I didn't need to go. The rest of that day I still had the hives, tightness, wheezing, and shortness of breath but when I woke up the next day it was all gone.
Pt has hypoarrhythmia-modified, infantile spasms & developmental delay; not recognized until p/3rd shot; p/2nd shot, in retrospect, pt abnormal;
rash on face, scalp neck and chest. OTC Benadryl. Lessened the itch a little .
Pt was vaccinated at age 17 years old for 1st & 2nd dose of COVID-19 moderna vaccine.  Pt stated she had no known adverse affects
Vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (Vertigo) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 2 dosage form. On 18-Apr-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced VERTIGO (Vertigo). At the time of the report, VERTIGO (Vertigo) outcome was unknown. Not Provided          This case was linked to US-MODERNATX, INC.-MOD-2021-083759 (E2B Linked Report). This case was linked to MOD-2021-080242 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-083759:cross linked case
Fever, Tmax 103.8.  Multiple tonic / clonic seizures in 1st 24hrs after vaccine admin. (currently 5). ER: CT+LP.  Still febrile lasts  seizure 1030 am 5/27/09.
severe pain in upper left arm, site of pneumonia shot earlier in day; inability to lift arm higher than mid-chest
Pt has redness, warmth, and swelling at vaccine site. Approximately 4x3 inches. She had 1st vaccine as child.